Ads
related to: treatment of insomnia in the elderly women over 60- Efficacy Data
Read Our
Clinical Trial Data
- Safety Information
Get Details on Our
Safety Profile
- FAQs
Have a Question?
Get Answers
- Demonstrated Safety
Safety Was Evaluated In Adults
With Insomnia. Know More.
- Efficacy Data
Search results
Results From The WOW.Com Content Network
It is not advisable to prescribe somnifacients for routine insomnia treatment, and they should only be used for short periods in patients who are severely distressed or with transient insomnia. [40] An important drawback of prolonged use is that it can result in rebound insomnia and withdrawal syndrome upon discontinuation. [ 40 ]
Insomnia affects people of all age groups, but people in the following groups have a higher chance of acquiring insomnia: [85] Individuals older than 60; History of mental health disorder including depression, etc. Emotional stress; Working late night shifts; Traveling through different time zones [12]
This has led to the Z-drugs becoming widely prescribed for the treatment of insomnia particularly in elderly patients. [13] [14] [15] Almost a third of all prescriptions written for Z-drugs are for adults over the age of 65. [16] Long-term use is not recommended as tolerance and addiction can occur. [17]
Women, people who work nights, and seniors are among those most at risk. It often runs in families, and recently, experts concluded that COVID-19 can trigger new insomnia.
For many over 65, a night of undisturbed sleep is not an option. The causes are varied, including menopause and sleep apnea. See what might keep you up.
There has also been research into the utility of the individual components of CBT-I, when delivered as monotherapies or multi-component therapies without cognitive therapy. A 2023 systematic review [39] demonstrated that just stimulus control and sleep restriction are effective treatment options for insomnia in older adults. It also indicated ...
Ad
related to: treatment of insomnia in the elderly women over 60